InvestmentJul 7, 2026, 08:01 PM
Bone Biologics Raises $3.0M in Private Placement
AI Summary
Bone Biologics Corp. has entered into a definitive agreement for a private placement with a single healthcare-focused institutional investor, raising approximately $3.0 million in gross proceeds. The offering includes 2,112,677 shares of common stock (or pre-funded warrants) and accompanying Series F and Series G warrants, priced at $1.42 per share/warrant. The company intends to use the net proceeds to fund clinical trials, maintain and extend its patent portfolio, and for working capital and other general corporate purposes.
Key Highlights
- Raised approximately $3.0 million in gross proceeds from the private placement.
- Issued 2,112,677 shares of common stock (or pre-funded warrants) and Series F & G warrants.
- Purchase price set at $1.42 per share/pre-funded warrant and accompanying warrants.
- Series F and G warrants have an exercise price of $1.42 per share.
- Potential additional gross proceeds of approximately $6.0 million if warrants are fully exercised.
- Net proceeds to fund clinical trials, patent portfolio, and general corporate purposes.
Price Impact
More from BBLG